FDA Inspection 1244293 — Chongqing Huapont Shengchem Pharmaceutical Co Ltd
The FDA completed an inspection of Chongqing Huapont Shengchem Pharmaceutical Co Ltd on Jun 21, 2024 in Hechuan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 21, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hechuan (China)